Level of serum soluble lumican and risks of perioperative complications in patients receiving aortic surgery
Open Access
- 4 March 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3), e0247340
- https://doi.org/10.1371/journal.pone.0247340
Abstract
Several serum biomarkers have been investigated for their potential as diagnostic tools in aortic disease; however, no study has investigated the association between serum biomarkers and outcomes after aortic surgery. This study explored the predictive ability of serum soluble lumican in postoperative outcomes after aortic surgery. In total, 58 patients receiving aortic surgery for aortic dissection or aneurysm at Linkou Chang Gung Memorial Hospital in Taiwan in December 2011–September 2018 were enrolled. Blood samples were collected immediately upon patients’ arrival in the intensive care unit after aortic surgery. The diagnostic properties of soluble lumican levels were assessed by performing receiver operating characteristic (ROC) curve analysis. The confidence interval (CI) of the area under the ROC curve (AUC) was measured using DeLong’s nonparametric method and the optimal cutoff was determined using the Youden index. The serum soluble lumican level distinguished prolonged ventilation (AUC, 73.5%; 95% CI, 57.7%–89.3%) and hospital stay for >30 days (AUC, 78.2%; 95% CI, 61.6%–94.7%). The optimal cutoffs of prolonged ventilation and hospital stay for >30 days were 1.547 and 5.992 ng/mL, respectively. The sensitivity and specificity were respectively 100% (95% CI, 71.5%–100%) and 40.4% (95% CI, 26.4%–55.7%) for prolonged ventilation and 58% (95% 27.7%–84.8%) and 91.3% (95% CI, 79.2%–97.6%) for hospital stay for >30 days. The serum soluble lumican level can be a potential prognostic factor for predicting poor postoperative outcomes after aortic surgery. However, more studies are warranted in the future.Funding Information
- Ministry of Science and Technology, Taiwan (108-2314-B-182A-141)
- Chang Gung Memorial Hospital, Linkou (CMRPG3J0661)
This publication has 27 references indexed in Scilit:
- Biomarkers of aortic diseasesAmerican Heart Journal, 2013
- Quantitative Proteomics Analysis by Isobaric Tags for Relative and Absolute Quantitation Identified Lumican as a Potential Marker for Acute Aortic DissectionJournal of Biomedicine and Biotechnology, 2011
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic DiseaseJournal of the American College of Cardiology, 2010
- Response to Letter Regarding Article, “Diagnosis of Acute Aortic Dissection by D-Dimer: The International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) Experience”Journal of the American College of Cardiology, 2010
- Circulating Transforming Growth Factor-β in Marfan SyndromeJournal of the American College of Cardiology, 2009
- Diagnosis of Acute Aortic Dissection by D-DimerJournal of the American College of Cardiology, 2009
- Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissectionEuropean Heart Journal, 2008
- Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissectionJournal of Cardiovascular Medicine, 2006
- Nonneurologic morbidity and profound hypothermia in aortic surgeryThe Annals of Thoracic Surgery, 2004
- Effects of the extracellular matrix on lumican expression in rat aortic smooth muscle cellsin vitroThe Journal of Pathology, 2001